Aspargo Laboratories Inc., a private specialty pharmaceutical company based in Englewood Cliffs, announced May 4 it acquired prescription brand Bandol from Laboratorios Rubio S.A., headquartered in ...
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful ...
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful ...
Company acquires international rights to Sildenafil Oral Spray from Farmalider, S.A. for 5 million shares of Aspargo common stock Acquisition follows the Company's recent completion of a $7.5 million ...
Experienced financial leader joins as the company prepares for its public market entry NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., ("Aspargo Labs” or the "Company”), a specialty ...
(MENAFN- GlobeNewsWire - Nasdaq) Life sciences marketing executive Andrew Chamlin will drive Aspargo Lab's global growth in revolutionizing the way medications are delivered NEW YORK, Nov. 19, 2024 ...
Dosing complete for 53 subjects in Sildenafil Oral Suspension Bioavailability Study Initiated dosing in 38 subjects in Sildenafil Oral Suspension Food-Effect Study Top-line data from both studies ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
The CEO discusses his company’s platform that helps reformulate oral solid dose medications to liquid forms. Aspargo Labs uses a proprietary technology platform to reformulate oral medication to ...
In an advance that could significantly lighten the load for caretakers in the “sandwich generation” and reduce loneliness in elderly patients, Aspargo Labs Inc. developed a metered delivery device ...
Aspargo Labs pre-IPO overview from MarketWatch. IPO content provided by Renaissance Capital LLC, manager of IPO-focused ETFs (tickers IPO, IPOS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results